BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases

NCT03318549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2024-11-26

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to better understand the impact of visual impairment caused by different eye diseases on the ability to perform daily activities and compare it to that in patients without eye diseases.

Conditions

  • Glaucoma
  • Macular Degeneration
  • Glaucoma Suspect
  • Optic Neuropathy
  • Retinal Degeneration
  • Visual Pathway Disorder

Interventions

DIAGNOSTIC_TEST

Visual Performance tests

Participants came to the clinic in person for 2 hours for visual performance tests once every 6 months for up to 5 years. These tests included virtual reality tests and tests on a computer screen to investigate performance during simulated daily life activities, such as driving, situations of low contrast and glare.

DEVICE

Brain-computer interface

The brain-computer interface (BCI) consists of a modified virtual reality goggle integrated with wireless no-prep electroencephalogram (EEG). The portable BCI is able to objectively measure multifocal steadystate visual evoked potentials in response to brain stimulation through presentation of visual stimuli in the goggle. The test is done in person and may take up to 30 minutes, once every 6 months for up to 5 years.

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH
  • University of Miami

    lead OTHER

Principal Investigators

  • Felipe A Medeiros, MD, PhD · University of Miami

  • Henry Tseng, MD, PhD · Duke University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-29
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03318549 on ClinicalTrials.gov